The World of Health & Medicine News

WHO to back use of weight-loss drugs for adults globally, raises cost issue

WHO to back use of weight-loss drugs for adults globally, raises cost issue

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first time, a memo reviewed by Reuters on Thursday showed, marking a shift in its approach to treating the global health problem.

The UN agency also called for strategies to improve access to the treatment in low- and middle-income countries.

More than a billion people now have obesity worldwide, according to the WHO, and around 70% of them live in low and middle-income countries, the World Bank estimates.

spot_img

Explore more

spot_img

Three minutes of moderate activity a day may reduce risk of...

Three minutes of moderate activity a day may reduce risk of having a cardiovascular event A team of cardiovascular and public health researchers affiliated with...

AstraZeneca’s ‘smoker’s lung’ therapy meets main goals of late-stage asthma trials

AstraZeneca's 'smoker's lung' therapy meets main goals of late-stage asthma trials  AstraZeneca (AZN.L), opens new tab said on Friday its triple-combination inhaler Breztri Aerosphere met all main...

 US FDA accepts Novo Nordisk’s application for oral Wegovy for weight...

 US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss The U.S. Food and Drug Administration has accepted Novo Nordisk's (NOVOb.CO), opens new tab marketing...

Neuralink’s speech restoration device gets FDA’s ‘breakthrough’ tag

Neuralink's speech restoration device gets FDA's 'breakthrough' tag Neuralink has received the U.S. Food and Drug Administration's "breakthrough" tag for its device to restore communication...

Novartis to buy kidney disease drug maker Regulus in up to...

Novartis to buy kidney disease drug maker Regulus in up to $1.7 billion deal Novartis (NOVN.S), opens new tab has agreed to buy Regulus Therapeutics (RGLS.O), opens...

UK’s Genus secures FDA approval for PRP gene edit; shares soar

UK's Genus secures FDA approval for PRP gene edit; shares soar  British animal genetics company Genus (GNS.L), opens new tab on Wednesday said the U.S. Food and...

WHO warns Trump cuts put millions of HIV patients at risk

WHO warns Trump cuts put millions of HIV patients at risk The World Health Organisation (WHO) has raised serious concerns that HIV medication shortages sparked by cuts to USAID will increase resistance to...

Boehringer drug delivers ‘unprecedented’ result in lung cancer study

Boehringer drug delivers 'unprecedented' result in lung cancer study An experimental Boehringer Ingelheim drug achieved “unprecedented” benefits in patients with an advanced form of lung...